Skylands Capital LLC Purchases 72,700 Shares of The Joint Corp. (NASDAQ:JYNT)

Skylands Capital LLC increased its holdings in shares of The Joint Corp. (NASDAQ:JYNTFree Report) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 738,728 shares of the company’s stock after acquiring an additional 72,700 shares during the quarter. Joint makes up about 1.1% of Skylands Capital LLC’s holdings, making the stock its 24th largest position. Skylands Capital LLC owned about 4.93% of Joint worth $7,853,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of JYNT. Los Angeles Capital Management LLC increased its stake in shares of Joint by 13.4% in the third quarter. Los Angeles Capital Management LLC now owns 89,964 shares of the company’s stock worth $1,029,000 after purchasing an additional 10,641 shares in the last quarter. Verus Capital Partners LLC raised its holdings in Joint by 5.9% during the 3rd quarter. Verus Capital Partners LLC now owns 132,955 shares of the company’s stock valued at $1,521,000 after acquiring an additional 7,440 shares during the period. Douglass Winthrop Advisors LLC raised its holdings in Joint by 4.1% during the 3rd quarter. Douglass Winthrop Advisors LLC now owns 146,400 shares of the company’s stock valued at $1,675,000 after acquiring an additional 5,800 shares during the period. FMR LLC boosted its holdings in shares of Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company’s stock worth $123,000 after acquiring an additional 2,971 shares during the period. Finally, BNP Paribas Financial Markets boosted its holdings in shares of Joint by 5.4% in the third quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock worth $258,000 after acquiring an additional 1,156 shares during the period. Institutional investors own 76.88% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on JYNT shares. Roth Mkm decreased their price target on Joint from $16.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. StockNews.com upgraded shares of Joint from a “hold” rating to a “buy” rating in a research report on Friday, November 15th.

Get Our Latest Stock Report on Joint

Joint Stock Down 0.1 %

JYNT opened at $11.35 on Monday. The business’s fifty day simple moving average is $10.89 and its 200 day simple moving average is $11.20. The Joint Corp. has a 52 week low of $9.10 and a 52 week high of $17.82. The stock has a market cap of $170.07 million, a PE ratio of -9.96 and a beta of 1.60.

About Joint

(Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

See Also

Want to see what other hedge funds are holding JYNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Joint Corp. (NASDAQ:JYNTFree Report).

Institutional Ownership by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.